Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Levels of Health Promotion and Illness Prevention

Levels of Health Promotion and Illness Prevention

Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Diabetes: Symptoms, Diagnosis, and Complications

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...

Oral Hypoglycemic Agents: Biguanides and Glitazones

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Public Health.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Same author

Effects of exercise versus usual care on older adults with amnestic mild cognitive impairment: EXERT versus ADNI.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Same author

Effects of exercise on cognition and Alzheimer's biomarkers in a randomized controlled trial of adults with mild cognitive impairment: The EXERT study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Same author

Advancing Chrononutrition for Cardiometabolic Health: A 2023 National Heart, Lung, and Blood Institute Workshop Report.

Journal of the American Heart Association·2025

Same author

Lessons Learned from National Heart, Lung, and Blood Institute Covid-19 Clinical Trials.

NEJM evidence·2024

Same author

Prospects for the future: supporting the elimination of rheumatic heart disease - a National Heart, Lung, and Blood Institute Workshop Proceedings.

BMJ global health·2023

Search research articles

Related Experiment Videos

Translating diabetes prevention programs: implications for dissemination and policy.

Jeffrey A Katula¹, Caroline S Blackwell, Erica L Rosenberger

¹Wake Forest University School of Medicine, PO Box 7868, Winston-Salem, NC 27109, USA. katulaj@wfu.edu

North Carolina Medical Journal

|March 16, 2012

Summary

Community-based translations of the Diabetes Prevention Program (DPP) show encouraging results. This commentary details one such study, Healthy Living Partnerships to Prevent Diabetes, and discusses policy implications.

Related Experiment Videos

Area of Science:

Public Health
Preventive Medicine
Health Services Research

Background:

The Diabetes Prevention Program (DPP) is a proven lifestyle intervention for preventing type 2 diabetes.
Translating the DPP into community-based settings is crucial for widespread public health impact.
Previous DPP translations have demonstrated feasibility and effectiveness in diverse populations.

Purpose of the Study:

To discuss the Healthy Living Partnerships to Prevent Diabetes (HLP2D) study, a community-based DPP translation.
To analyze the successes and challenges of implementing the HLP2D program.
To explore the broader implications of DPP translational research for public policy and diabetes prevention.

Main Methods:

This is a commentary discussing a specific translational study.
It involves a detailed review of the Healthy Living Partnerships to Prevent Diabetes (HLP2D) program.
The commentary synthesizes findings from the HLP2D study and relates them to existing DPP literature.

Main Results:

Community-based DPP translations, like HLP2D, are feasible and yield positive outcomes.
Successful translation requires community engagement and tailored approaches.
Translational research provides valuable data for informing public health policy.

Conclusions:

The Healthy Living Partnerships to Prevent Diabetes study exemplifies successful community-based DPP translation.
Effective DPP implementation in community settings can significantly impact diabetes prevention efforts.
Translational findings from DPP studies should guide policy decisions to support widespread diabetes prevention initiatives.